Literature DB >> 3364950

Comparative toxicities of cephalosporin antibiotics in a rabbit kidney cell line (LLC-RK1).

P D Williams1, D A Laska, L K Tay, G H Hottendorf.   

Abstract

The rabbit kidney cell line LLC-RK1 was tested for its ability to discriminate the toxicities of six cephalosporin antibiotics according to their in vivo nephrotoxic potentials in rabbits. With the exception of cephalothin, which was markedly toxic to kidney cells in vitro, a good correlation between in vitro toxicity and in vivo nephrotoxicity was obtained, yielding the following toxicity rank order: ceftazidime less than cefazolin approximately cefoperazone less than cephaloglycin approximately cephaloridine. The addition of a kidney microsomal S9 fraction to the cell cultures desacetylated cephalothin as occurs in vivo and detoxified this antibiotic, providing it with the proper toxicity relative to the other cephalosporins. When compared with parent structures, desacetylated derivatives of other cephalosporins such as cephapirin were similarly found to be less toxic to LLC-RK1 cells. The acetylated cephalosporin cephaloglycin was not detoxified by the kidney S9 fraction and was desacetylated three to four times slower than cephalothin by renal esterases. Thus, the rate and extent of desacetylation of cephalosporins may play a role in their in vivo nephrotoxic potential. Our results further suggest that LLC-RK1 cells will provide a useful model for evaluating the potential nephrotoxicity of new cephalosporin antibiotics before in vivo studies.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3364950      PMCID: PMC172166          DOI: 10.1128/AAC.32.3.314

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Relationship between the transport and toxicity of cephalosporins in the kidney.

Authors:  B M Tune
Journal:  J Infect Dis       Date:  1975-08       Impact factor: 5.226

2.  DEVELOPMENT AND CHARACTERISTICS OF THE RABBIT KIDNEY CELL STRAIN, LLC-RK.

Authors:  R N HULL; A C DWYER; W R CHERRY; O J TRITCH
Journal:  Proc Soc Exp Biol Med       Date:  1965-04

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Penetration of cefamandole, cephalothin, and desacetylcephalothin into fibrin clots.

Authors:  M G Bergeron; B M Nguyen; S Trottier; L Gauvreau
Journal:  Antimicrob Agents Chemother       Date:  1977-12       Impact factor: 5.191

5.  On the pharmacokinetics of cephalosporin antibiotics.

Authors:  K E Andersson
Journal:  Scand J Infect Dis Suppl       Date:  1978

6.  Acute toxicity of cephaloridine, an antibiotic derived from cephalosporin C.

Authors:  R M Atkinson; J P Currie; B Davis; D A Pratt; H M Sharpe; E G Tomich
Journal:  Toxicol Appl Pharmacol       Date:  1966-05       Impact factor: 4.219

7.  Automated colorimetric assay for T cell cytotoxicity.

Authors:  C R Parish; A Müllbacher
Journal:  J Immunol Methods       Date:  1983-03-11       Impact factor: 2.303

8.  Cephaloridine-induced lipid peroxidation initiated by reactive oxygen species as a possible mechanism of cephaloridine nephrotoxicity.

Authors:  C Cojocel; J Hannemann; K Baumann
Journal:  Biochim Biophys Acta       Date:  1985-05-17

9.  Role of desacetylation in the detoxification of cephalothin in renal cells in culture.

Authors:  G H Hottendorf; D A Laska; P D Williams; S M Ford
Journal:  J Toxicol Environ Health       Date:  1987

10.  Metabolism of D-cephaloglycin-14C and L-cephaloglycin-14C in the rat.

Authors:  H R Sullivan; R E Billings; R E McMahon
Journal:  J Antibiot (Tokyo)       Date:  1969-01       Impact factor: 2.649

  10 in total
  1 in total

1.  Comparative impact of cephaloridine on glutathione and related enzymes in LLC-PK1, LLC-RK1, and primary cultures of rat and rabbit proximal tubule cells.

Authors:  J P Morin; S Marouillat; C Lendormi; C Monteil
Journal:  Cell Biol Toxicol       Date:  1996-12       Impact factor: 6.691

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.